Between 2009 and 2017, the occurrence of healthcare-related infections in Canadian hospitals has reduced by 30%, further declining to 7.9% as reported by researchers.
Shelley S. Magill, MD, Ph.D., a medical officer in the CDC’s Division of Healthcare Quality Promotion, and colleagues last year The New England Journal of Medicine that the occurrence of health-care-associated (HAIs) fell to 3.2% in 2011.
Geoffrey Taylor, MD, University of Alberta’s professor of medicine for infectious diseases and senior medical director of infection prevention and control at Alberta Health Services, informed Infectious Disease News that the Hospital infection occurrence surveys are directly related to the population under observation, so direct assessments are tough to carry out.
Geoffrey Taylor further added that their research included big urban tertiary hospitals and omitted very low-risk units, such as maternity. Magill [and colleagues] recently carried out a study where they included lower risk hospitals and they discovered lower infection rates. The levels of resistance to MRSA (31%) and carbapenemase (negligible) observed in hospital diseases were slightly smaller than Magill (45% and 5% respectively).
Taylor and colleagues evaluated the burden of HAIs through descriptive point-prevalence surveys carried out by The Canadian Nosocomial Infection Surveillance Program. In February 2002, 2009, and 2017, the studies recorded single-day infections including UTIs, pneumonia, Clostridioides diffici infections (CDIs), surgical site infections (SSIs), and bloodstream infections.
The occurrence of at least on HAI in patients in 2002 was 9.9%. it has risen to 11.3% in 2009 and then decreased to 7.9% in 2017.
Taylor also added that this promotes the conclusion that Canadian hospitals have introduced various infection reduction approaches, such as enhanced hand hygiene, ‘ bundled ‘ prevention measures such as central venous catheter bundles, antimicrobial management.
Jennie Johnstone, MD, PhD, physician co-leader of infection prevention and control at the Sinai Health System and assistant professor at the Dalla Lana School of Public Health at the University of Toronto, and peers clarified in a commentary that although the results of the research are “compelling,” they signal a “successful” starting rather than ending the battle against HAIs